Circulating Tumor Cells analysis

Circulating tumor cells (CTCs) are cancer cells that have detached from the primary or metastatic tumor and entered the bloodstream. The transfer of cancer cells through the circulatory system is often a significant factor in the mortality of cancer patients. Therefore, the detection of CTCs can be used for early tumor detection and for monitoring cancer recurrence and metastasis. The use of microfluidic cell separation technology to detect circulating tumor cells is the latest medical cancer detection method. By analyzing the changes in the quantity of circulating tumor cells, it can be used to evaluate the effectiveness of cancer treatment and monitor recurrence.

Product Introduction

The test is performed using 8mL of peripheral whole blood for analysis, and tumor cells are captured from peripheral blood using tumor cell-specific antibodies and tumor cell size. The blood sample is processed using a special patented technology to isolate and purify the tumor cells into a special patented microchannel chip structure. The cells are then fixed and stained with specific antibodies for high-resolution imaging using a camera and fluorescence microscope. Subsequently, artificial intelligence image analysis software is used to identify and count the circulating tumor cells.

Achievement

Clinical Outcomes (Charts)

Certification/Award

CAP ACCREDITED

Contact Information

Unit/Telephone (including extension)/E-Mail